NEWS      WELCOME      CONTACT EMN      EMN SO      EMN TRIALS      EMN TRIAL GROUP      EMN BIOLOGY GROUP      LOGIN      MSCNET

 Updated on: Jan 9 2014

EMN Board Meeting

 

26 June 2012

 

Dear EMN members. 

 

EMN board meeting was held on 15 June 2012  at the European Haematology Association Congress in Amsterdam.

 

Minutes of the board meeting

 

The next board meeting is planned to be on 2 November 2012 at Copenhagen Airport.

 

Scientific Working Group Meeting

 

18 June 2012

 

Dear EMN members. 
 

A Scientific Working Group meeting was held in Amsterdam on 14 June 2012 at the European Haematology Association Congress in Amsterdam, www.ehaweb.org.

The topic was “The next steps in MM care?”

Please find programme and presentations for the session below:

 

SWG MM programme at EHA 14 June 2012, Amsterdam 

 

Treatment of relapsed and refractory multiple myeloma  

 

Prognostic relevance of 18F-FDG PET/CT in newly diagnosed myeloma 

 

Evolving paradigms in elderly frail patients 

 

Clinical advances for the treatment of RRMM - is myeloma becoming a chronic disease

 

 

 

EMN Baveno Meeting

 

1 June 2012

 

Dear EMN members. 

 

Please find summary of the Baveno meeting of 13 and 14 May 2012 here 

 

 

Investigators Meeting

 

24 May 2012

 

Dear EMN members. 

 

EMN will hold an investigators meeting in Amsterdam on Friday 15 June 2012 at the European Haematology Association Congress in Amsterdam, www.ehaweb.org.

 

The topic is discussion on a new side study of the EMN02 study of Allo-SCT for high risk MM and plasmacell leukaemia. Please find attached background and an advanced draft of the protocol.

The meeting will be held at the Congress Venue, Amsterdam RAI, Europaplein 22, room G108 on 15 June, at 16.00 – 18.00 p.m.

 

Please find background and an advanced draft of the protocol attached:

 

Background investigators meeting

 

MM-high-risk-May 2012

 

 

Presentations from the European Myeloma Network Flow Cytometry Worskshop, 2010


THE EUROPEAN MYELOMA NETWORK
FLOW CYTOMETRY WORKSHOP


 

 

 

 Focused on Minimal residual disease monitoring in the European Intergroup Trial EMNIT

 

 

Workshop Agenda

Dates: 23 October 2010
Time: 08:30-19:00
Place: Cancer Research Center (CICancer) & University Hospital, Salamanca

 

 

08:30-09:00

The European Myeloma Network Intergroup Trial (EMNIT) and the MRD protocol - "hypothesis, goals and organization (H.E. Johnsen)

 

09:00-10:00

Maturation associated subsets of BM and PB B-cells in nrmal individuals and patients with plasma cell dyscrasias as characterized by multiparametric flow cytometry (M. Perez-Andreas)

 

10:00-11:30

Immunophenotypic analysis of normal vs. neoplastic PC: basis principles of flow cytometer, techniques and panels for cell surface and/or intracytoplasmatic staining (A. Orfao)

 

11:30-12:00

Coffee Break

 

12:00-13:00

 Medical indications for flow cytometry analysis of PC and sorting in plasma cell dyscrasias ( J. Almeida)

 

13:00-14:30

Lunch

 

14:30-17:30

Practical sessions (A. Orfao, J. Almeida, M. Pérez-Andrés, B. Paiva, A. Schmitz, JA Flores)

- Immunophenotypic identification and characterization of PC in MGUS, MM, PCL and WM patients

- Flow cytometric evaluation of plasma cell proliferation in myeloma

- Minimal residual disease evaluation by flow cytometry

- Storage of data

 

17:30-18:30

The EMN common data bank – the next step (HE Johnsen/A Orfao)

 

18:30-19:00

 Closing session (discussion)

Secr. Hans E. Johnsen | Depart. of Haematology | Aalborg University Hospital | Sdr. Skovvej 15 | DK-9000 Aalborg | Denmark | T:+45 9766 3871 | F:+45 9766 6369